Latest / Cleveland Clinic Cancer Advances
Tumor-Infiltrating Lymphocyte (TIL) Therapy
Thach-Giao Truong, MD, Director of the Melanoma Program at Cleveland Clinic, joins the Cancer Advances podcast to discuss Tumor-Infiltrating Lymphocyte (TIL) therapy. This cutting-edge, personalized cancer treatment utilizes a patient's immune cells to target and destroy tumors. Listen as Dr. Truong provides insights into the science behind TIL therapy, its advantages, and its potential to revolutionize treatment for patients with resistant melanoma and other challenging cancers.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.